Haoxi Health Technology Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021
Market Capitalization	159	-	-	-
Enterprise Value	159	-0	0	0
PE Ratio	92.31	-	-	-
PS Ratio	3.74	-	-	-
PB Ratio	92.51	-	-	-
EV/Sales Ratio	3.74	-0.01	0.01	0.02
EV/EBITDA Ratio	-	-0.29	0.78	0.84
EV/EBIT Ratio	103.68	-0.29	0.79	0.84
EV/FCF Ratio	-	0.38	-0.31	0.11
Debt / Equity Ratio	0.59	0.54	-0.34	-0.17
Debt / EBITDA Ratio	-	0.70	1.86	1.01
Debt / FCF Ratio	-	-0.93	-0.74	0.13
Quick Ratio	0.32	0.47	0.16	0.43
Current Ratio	1.31	1.43	0.22	0.56
Asset Turnover	9.28	11.28	9.63	-
Interest Coverage	49.62	57.95	27.06	62.72
Return on Equity (ROE)	92.90%	1923.70%	-14.40%	-
Return on Assets (ROA)	28.00%	38.70%	14.60%	-
Return on Capital (ROIC)	47.27%	40.31%	-3069.54%	-19.36%
Earnings Yield	0.81%	-	-	-
Buyback Yield / Dilution	-17.92%	-10.45%	-	-
Total Shareholder Return	-17.92%	-10.45%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).